Most Recent
Casino gaming giant Aristocrat may sue competitor Light & Wonder and two former employees who jumped ship for allegedly misusing confidential information about its popular Lightning Link and Dragon Link games to develop a competing product.
After a seven-year legal battle, a court has upheld the validity of Neurim Pharmaceutical’s patent for insomnia drug Circadin and ruled two generic drug companies infringed the intellectual property.
A judge has issued a self-executing order for the dismissal of a patent infringement lawsuit against Monster Energy if the inventor who brought the case fails to pay $350,000 in security for the beverage giant's costs within two weeks.
An appeals court has ordered a third trial in a long-running copyright battle between Microsoft and a Melbourne computer retailer, saying the trial judge's findings were "greatly diminished" by her three-year-long delay in delivering judgment.
Online marketplace Redbubble has succeeded on appeal in cutting down the damages it owes to Hells Angels from over $78,000 to just $100, following a finding that it violated the motorcycle group’s trade marks.
The maker of Finish dishwashing products, RB Hygiene, has won a partial appeal in a trade mark stoush with rival Henkel, with the Full Court reviving two of its trade marks but rejecting its challenge to a logo for competing Somat-branded products.
South Korean biosimilars company Samsung Bioepis has sued Johnson & Johnson's Janssen Biotech to invalidate two patents for Crohn's disease drug Stelara, after reaching a licencing agreement over the medicine in the US.
The security sum sought by Monster Energy from an inventor suing the beverage giant for patent infringement was "manifestly excessive", a judge has said, and was based on an estimate of costs that included the fees of three solicitors and two barristers at an interlocutory hearing.
Just days before trial, exercise bike giant Peloton Interactive has dropped its lawsuit against California fitness company Mad Dogg Athletics that sought removal of Mad Dogg's 'spinning' trade mark.
A judge has upheld findings from IP Australia that South Korean biotech ToolGen's genome editing technology CRISPR is not patentable, but given the company one more chance to seek to amend its application.